Please login to the form below

Not currently logged in
Email:
Password:

PCTs

This page shows the latest PCTs news and features for those working in and with pharma, biotech and healthcare.

Summit takes clinical trial participant search online

Summit takes clinical trial participant search online

If Summit can bring ezutromid to market it will compete with PCT Therapeutics' Translarna, which was recommended by NICE in England and Wales earlier this year, and potentially.

Latest news

  • India denies Vertex patent on cystic fibrosis drug Orkambi India denies Vertex patent on cystic fibrosis drug Orkambi

    The rejection of the International Patent Application ( No. PCT/US2008/085456) covers solid forms of lumacaftor one of the active ingredients in Orkambi which to date has been launched onto the

  • Good practice in blood clot care recognised at awards Good practice in blood clot care recognised at awards

    His achievements include establishing GPwSI cardiology service for North Bradford PCT and serving as a member of the NICE Atrial Fibrillation Guideline Development Group.

  • Dawn of the new world Dawn of the new world

    Out went SHAs, PCTs and any number of ALBs. In came NHSE, PHE and CCGs. . ... For example, if you manufacture cancer drugs, then you will have moved from having 151 PCTs to engage with to a single commissioner – NHS England.

  • Is the new NHS guidance relevant to pharma? Is the new NHS guidance relevant to pharma?

    The new NHS planning guidance for Clinical Commissioning Groups (CCGs), Everyone Counts: Planning for Patients 2013/14, which will take over from Primary Care Trusts (PCTs) in England, this April.

  • NHS London PR spend criticised

    Tower Hamlets PCT, which spent £353, 391 in outsourced PR over the last three years, insisted much of the spend was on public health campaigns with real value.

More from news
Approximately 0 fully matching, plus 207 partially matching documents found.

Latest Intelligence

  • Healthcare systems

  • England’s clinical commissioning landscape England’s clinical commissioning landscape

    The PCT model was in place for more than a decade, so it will take time to fully assess the impact of clinical commissioning.

  • UK market access: The importance of a local value story UK market access: The importance of a local value story

    creation. Major structural reforms abolished the 151 former Primary Care Trusts (PCTs) that made commissioning decisions, replacing them with 211 Clinical Commissioning Groups (CCGs), led by family doctors. . ... that they are made up of many ex-PCT

  • NHS Health Reforms

    The expert panel includes. Michael Sobanja, chief executive, NHS Alliance. Mark Wilkinson, director of life sciences innovation for the NHS and former PCT chief executive.

  • Evidence-based patient pathways for mCRC Evidence-based patient pathways for mCRC

    A variety of independent pathways for mCRC patients with liver metastases exist across the UK and are used at the discretion of Primary Care Trusts (PCTs). ... The first step focused on drafting a preliminary pathway based on individual PCT pathways,

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics